2016 American Transplant Congress » Concurrent Session: Kidney Immune Monitoring 1

4:30pm-4:42pm

A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Response in the Sailor Randomized Multicenter Trial.

J. Ekberg,¹ B. Jespersen,² K. Skov,² M. Sarwal,³ T. Sigdel,³ S. Hsieh,³ P. Lindner.¹

4:42pm-4:54pm

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.

J. Ho,¹ A. Sharma,² R. Mandal,³ D. Wishart,³ C. Wiebe,¹ L. Storsley,¹ M. Karpinski,¹ I. Gibson,⁴ P. Nickerson,¹ D. Rush.¹

4:54pm-5:06pm

mRNA Expression of BAFF and APRIL Receptors Increases in Acute Rejection in Kidney Transplant Recipients.

M. Minz,¹ R. Dhital,¹ R. Minz,² A. Sharma,¹ R. Nada,³ S. Singh,¹ D. Kenwar.¹

5:06pm-5:18pm

MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation.

E. Gielis,^1,2 J. Anholts,² H. de Fijter,³ I. Bajema,⁴ F. Claas,² M. Eikmans.²

5:18pm-5:30pm

VDJ Immune Repertoire Sequencing Predicts Patients at Risk of Alloimmune Injury.

M. Sirota,¹ T. Sigdel,¹ S. Boyd,² A. Fire,² M. Sarwal.¹

5:30pm-5:42pm

Rapid Detection of Urinary CXCL9 as a Diagnostic and Prognostic Tool for Managing Acute Cellular Rejection (ACR) in Kidney Transplantation.

I. Gandolfini,¹ C. Harris,¹ C. Purroy,¹ V. Nair,¹ J. Reid-Adam,¹ O. Bestard,² P. Heeger.¹

5:42pm-5:54pm

Implications of Subclinical Borderline Acute Cellular Rejection Detected in Protocol Biopsies on Graft Outcomes.

Z. Zaky,¹ C. Yu,¹ N. Elfadawy,² A. Chiesa-Vottero,¹ L. Herlitz,¹ S. Flechner,¹ E. Poggio.¹